I’d buy this FTSE 100 stock, which looks set to thrive in a world with coronavirus

Despite near-term uncertainty, this company’s directors are “confident” about their long-term strategy. I think the firm looks set to continue its growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I last wrote about the FTSE 100’s integrated accounting, payroll, and payments solutions provider Sage (LSE: SGE) on 22 January when the share price was 771p.

The article was bullish and discussed how the company has been changing its business model to focus on building up recurring revenue by moving customers to cloud-based subscription services.

A FTSE 100 stock with a great trading record

Sage has a great track record of consistently growing revenue, earnings, cash flow and shareholder dividends. And the way the firm is adapting for the modern ways of doing business encourages me to believe there are many more good years ahead for shareholders.

Shortly after that previous article, the coronavirus crash happened. And by 23 March, the stock was as low as about 530p. In hindsight, that would have been a great entry point for new holders and would have neatly side-stepped the one issue that perhaps keeps investors away from Sage – namely, that the valuation has often looked full.

Since March, the share price has been storming back up and stands at 679p, as I write. But I’d still buy this stock and hold it for the long term. This a high-quality operation with ‘sticky’ revenues and, as such, I see it as an attractive growth-oriented and defensive investment. The recovery from the coronavirus crash demonstrates the firm’s resilience.  

Perhaps the most interesting figure in today’s half-year results report is the 2.5% increase in the interim dividend. I reckon that decision by the directors speaks volumes about how they see current trading and the immediate prospects of the business. To pay and increase the dividend when many other companies have axed theirs completely in this crisis strikes me as a sign of the strength of the enterprise.

Growing recurring revenue

The company saw an increase in “high quality” recurring revenue of just over 10% in the period. The measure reveals how successful the firm has been attracting new customers and migrating existing customers to subscription and Sage Business Cloud. Overall, organic revenue went up by just under 6%.

Within the figures, we can see the dynamics of Sage’s changing business model in play. There was an almost 26% increase in subscription-based revenue, offset by an almost 20% decline in other revenues. That was due to the managed decline in licence sales and “de-prioritisation” of professional services. Some 88% of the company’s revenue is now recurring, which makes the stock defensive and cash-generating. Ideal for sustaining the progressive shareholder dividend policy.

Covid-19 began to affect non-subscription revenue from the end of March. And now the company is beginning to see the broader effects of the sharp economic downturn caused by the pandemic. Some of the firm’s customers are deferring purchase decisions. Indeed, during April, new customer acquisition was roughly half the level the directors had previously expected.

However, Sage doesn’t intend to make any of its staff redundant and hasn’t furloughed anyone, or taken advantage of other government support schemes. Despite the near-term uncertainty, the directors are “confident” about the company’s long-term strategy. And I reckon Sage looks set to thrive in a world with coronavirus. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended Sage Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »